MedPath

Treatment of Biliary Obstruction Using Biliary Stent With or Without Antireflux Valve

Not Applicable
Terminated
Conditions
Biliary Obstruction
Cholangitis
Registration Number
NCT00990366
Lead Sponsor
Turku University Hospital
Brief Summary

Biliary obstruction can be relieved by biliary stent. Ascending infection of biliary passage (cholangitis) causes hospitalization and obstruction of stents. Reflux of intestinal fluids through a stent is thought to be one of the causes of cholangitis. Stents with antireflux valves are designed to reduce the reflux from the bowel. The purpose of the study is to investigate prospectively whether it is possible to reduce the amount of infection and thus obstruction of biliary stent by using a stent with an antireflux valve compared to a normal stent without an antireflux valve.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • age 18-89
  • biliary obstruction in the lower two thirds of the choledochus
Exclusion Criteria
  • allergy to contrast media
  • future pancreaticoduodenectomy
  • refusal from the study
  • previous stent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
patency of a biliary stentone year
Secondary Outcome Measures
NameTimeMethod
Cholangitisone year

Trial Locations

Locations (1)

Turku University Hospital

🇫🇮

Turku, Finland

Turku University Hospital
🇫🇮Turku, Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.